Zobrazeno 1 - 3
of 3
pro vyhledávání: '"A. I. Peltomaa"'
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract To compare the effect of statin use in relation to castration-resistant prostate cancer (CRPC) treatment, we assessed the risk of ADT-treated PCa-patients to initiate CRPC treatment by statin use and the outcomes of CRPC treatment by statin
Externí odkaz:
https://doaj.org/article/1366b304409d469482ca76bea1f8b26a
Autor:
Antti I. Peltomaa, Kirsi Talala, Kimmo Taari, Teuvo L. J. Tammela, Anssi Auvinen, Teemu J. Murtola
Publikováno v:
Cancers, Vol 14, Iss 12, p 2920 (2022)
Statins have been associated with a decreased cancer mortality. However, cholesterol level as such may modify the risk of cancer death. To clarify the complex interplay between statins, cholesterol level, and cancer mortality, we conducted a comprehe
Externí odkaz:
https://doaj.org/article/978c6dc18a4d4b6789101c3a720958a8
Autor:
Kirsi Talala, Liisa Määttänen, Antti I. Peltomaa, Teuvo L.J. Tammela, Anssi Auvinen, Kimmo Taari, Teemu J. Murtola
Publikováno v:
European Urology Focus. 3:212-220
Background Recent research has suggested that statins have an effect on prostate cancer prognosis. It is currently unclear how prostate cancer screening, tumor and patient characteristics, or treatment selection may affect this association. Objective